The Importance of Analytical Chemistry in Therapeutic Drug Monitoring for Personalized Medicine

Hamza Sofiyev, Neşet Neşetoğlu, Ibrahim Danış, Cem Kaplan, Merve Keşkek Arslan, Serap Sağlık Aslan, Durişehvar Özer Ünal

Abstract


Personalized therapy (PM) has the potential to adapt treatment with the best response and highest safety to provide better patient care. Key data is drug concentration of biological materials such as plasma and serum.Individual drug therapy means, choice of a drug and its dose regime should fit every individual specifically. Thus efficacy of a drug treatment would improve significantly. When developing an analytical method for (Therapeutic drug monitoring) TDM, it is important to choose a clinically relevant calibration range. This quantitation range should be built around the proposed target concentration, covering majority of samples as seen in the clinic (Ciocan-Cartita et al. 2019).Inter-individual variability in Pharmacokinetic variables may affect the blood concentration of drug so TDM approaches could solve the dosing problem.To achieve individual drug therapy with a reasonably predictive outcome, one must further account for different patterns of drug response among geographically and ethnically distinct populations.

Keywords: LC-MS/MS, Therapeutic Drug Monitoring, Lenalidomide, Anastrozole

DOI: 10.7176/CMR/12-7-05

Publication date:September 30th 2020


Full Text: PDF
Download the IISTE publication guideline!

To list your conference here. Please contact the administrator of this platform.

Paper submission email: CMR@iiste.org

ISSN (Paper)2224-3224 ISSN (Online)2225-0956

Please add our address "contact@iiste.org" into your email contact list.

This journal follows ISO 9001 management standard and licensed under a Creative Commons Attribution 3.0 License.

Copyright © www.iiste.org